Successful induction of molecular remission with single-agent anti-CD33 antibody (gemtuzumab ozogamicin) in chemotherapy-refractory relapse of acute myeloid leukaemia post-BMT

Ronan Swords, P. J. Hayden, K. Molloy, M. Lawlor, P. V. Browne, P. T. Murphy

Research output: Contribution to journalLetter

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)450-451
Number of pages2
JournalEuropean Journal of Haematology
Volume73
Issue number6
DOIs
StatePublished - Dec 2004

ASJC Scopus subject areas

  • Hematology

Cite this